We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
NVIDIA
NVDA
$4.72T
| $168M | 0.41% |
28,539,240
-660,000
| -2% | -$3.43M |
|
|
B
52
Barrick Mining
B
$63.2B
| $158M | 0.39% |
8,500,000
+500,000
| +6% | +$8.58M |
|
|
NBL
53
DELISTED
Noble Energy, Inc.
NBL
| $156M | 0.38% |
6,298,783
-2,515,058
| -29% | -$53.4M |
|
54
Accenture
ACN
$99.9B
| $156M | 0.38% |
739,100
-34,100
| -4% | -$6.65M |
|
55
Edison International
EIX
$30.3B
| $155M | 0.38% |
2,055,684
-19,800
| -1% | -$1.4M |
|
56
Philip Morris
PM
$299B
| $154M | 0.38% |
1,812,154
-76,400
| -4% | -$6.3M |
|
57
Thermo Fisher Scientific
TMO
$214B
| $152M | 0.37% |
467,486
-20,552
| -4% | -$6.23M |
|
58
Entergy
ETR
$50.4B
| $151M | 0.37% |
2,514,800
-195,000
| -7% | -$11.5M |
|
59
DuPont de Nemours
DD
$18.7B
| $150M | 0.37% |
1,863,367
+744,086
| +66% | +$61.8M |
|
|
60
Costco
COST
$423B
| $149M | 0.37% |
508,478
+449,819
| +767% | +$134M |
|
61
Linde
LIN
$235B
| $148M | 0.36% |
696,409
+20,300
| +3% | +$4.09M |
|
62
PayPal
PYPL
$49.3B
| $148M | 0.36% |
1,367,975
+72,600
| +6% | +$7.57M |
|
63
L3Harris
LHX
$50.7B
| $147M | 0.36% |
741,080
+377,147
| +104% | +$75.6M |
|
64
Kimberly-Clark
KMB
$36.6B
| $142M | 0.35% |
1,031,225
-52,028
| -5% | -$7.04M |
|
|
65
Bristol-Myers Squibb
BMY
$132B
| $142M | 0.35% |
+2,207,539
| New | +$126M |
|
66
Sarepta Therapeutics
SRPT
$1.64B
| $140M | 0.34% |
1,087,330
-637,626
| -37% | -$64.4M |
|
67
NextEra Energy
NEE
$183B
| $137M | 0.34% |
2,263,384
-113,588
| -5% | -$6.63M |
|
|
PXD
68
DELISTED
Pioneer Natural Resource Co.
PXD
| $134M | 0.33% |
884,330
-464,200
| -34% | -$61.8M |
|
69
Howmet Aerospace
HWM
$111B
| $131M | 0.32% |
5,534,883
+4,910,267
| +786% | +$110M |
|
70
Olin
OLN
$2.53B
| $129M | 0.32% |
7,469,782
-1,433,850
| -16% | -$25.7M |
|
71
Dominion Energy
D
$61.3B
| $129M | 0.32% |
1,552,215
+554,500
| +56% | +$45.3M |
|
72
Nike
NKE
$62.7B
| $128M | 0.32% |
1,266,938
+31,100
| +3% | +$2.93M |
|
73
Union Pacific
UNP
$172B
| $128M | 0.31% |
708,514
-149,400
| -17% | -$25.6M |
|
|
PE
74
DELISTED
PARSLEY ENERGY INC
PE
| $127M | 0.31% |
6,709,177
-2,795,000
| -29% | -$46.1M |
|
75
ITT
ITT
$17.3B
| $126M | 0.31% |
1,711,198
-318,031
| -16% | -$21.1M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.